ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

➤ Gửi thông báo lỗi ⚠️ Báo cáo tài liệu vi phạm

Loại tài liệu: PDF

Số trang: 45 Trang

Tài liệu: ✅ ĐÃ ĐƯỢC PHÊ DUYỆT

TẢI VỀ

Nội dung chi tiết: ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

CUPOPCAM soeierr or

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc and treatment of pulmonary hypertensionThe Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology

(ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)Authors/Task Force M ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

embers: Nazzareno Galiè (Chairperson) (Italy)*; Marius M. Hoeper (Germany);Marc Humbert (France); Adam Torbicki (Poland); Jean-Luc Vachicry (France);

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

Joan Albert Barbera (Spain);Maurice Beghetti (Switzerland); Paul Corris (UK); Sean Gaine (Ireland); J. Simon Gibbs (UK);Miguel Angel Gomez-Sanchez (Sp

CUPOPCAM soeierr or

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hocrland); Gerald Simonneau (France)ESC Committee for Practice Guidelines (CPG): Alec Vahanian (Chairperson) (France); Angelo Auricchio (Switzerland); Je

roen Bax (The Netherlands); Claudio Ceconi (Italy); Veronica Dean (France); Gerasimos Filippatos (Greece); Christian Funck-Brcntano (France); Richard ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

Hobbs (UK); Peter Kearney (Ireland); Theresa McDonagh (UK); Keith McGregor (France); Bogdan A. Popescu (Romania); Zeljko Reiner (Croatia); Udo Scchtcm

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

(Germany); Per Anton Sirnes (Norway); Michal Tendera (Poland); Panos Vardas (Greece); Petr Widimsky (Czech Republic)Document Reviewers: Udo Sechtem (

CUPOPCAM soeierr or

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hocy); Ray Benza (USA); Rolf Berger (The Netherlands); Damien Bonnet (France); Marion Delcroix (Belgium); Luke Howard (UK); Anastasia N Kitsiou (Greece);

Irene Lang (Austria); Aldo Maggioni (Italy); Jens Erik Nielscn-Kudsk (Denmark); Myung Park (USA); Pasquale Perrone-Filardi (Italy); Suzanna Price (UK ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

); Maria Teresa Subirana Domenech (Spain); Anton Vonk-Noordegraaf (The Netherlands); Jose Luis Zamorano (Spain)The disclosure forms of all the authors

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

and reviewers arc available on the ESC website www.cscardio.org/guidclincsIMPORTANT NOTE: Since the original publication of these Guidelines, the dru

CUPOPCAM soeierr or

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hocur Heort J 2011:32:386-387 and on the ESC website http://www.escardio.org/guidelines-surveys/esc-guidelines/Pages/pulmonary-arcerial-hypertension.aspx

). The instances where sitaxentan appears in this document have been highlighted in yellow.Downloaded freoi httpi.'-'cuibeitfti.Cixfordionir.sls.wg-' ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

by guest eu May 28. 2014Table of ContentsAbbreviations and acronyms..................................... 2494I’reamble................................

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

...................... 24951Introduclion...............................................24962Definitions...............................................

CUPOPCAM soeierr or

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hocf pulmonary hypertension...................... 24996Genetics, epidemiology, and risk factors of piZmonaryhypertension.................................

................25007Pulmonary arterial hypertension (group 1).............. 25017.1Diagiosis.......................................... 25027.1.1CTmĩc ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

al presentation.......................... 25027.1.2I kxtrocarcSogram............................. 25027.1.3Chest radiograph...........................

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

... 2502r Ccrrcspondng author. Inswutc of Cardologr. Bokogna Unvcrsicy Hosprat Vu Mỉísa-cntt 9. -40138 Bdogna. Italy. Tct I 39 051 349 858. fax ■ 39 0

CUPOPCAM soeierr or

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hocd use only. No ccrrmcrcol use a authorized. No part of the ESC Gudcknes may be translated or reproduced rn any form wtbout written permission from the

ESC Permission can be obtared upon submission of a written request to Oxford Unr/vrsty Plcss. the pvbleher of the tii'ojron Hron fnjmal and the party ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

authoriced to handc MKh primĩno-n on behalf 1/ the ESCDisclaimer. The ESC Gudelr.es represent the vows of the ESC and were anved at after ca-cfol ccr

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

nadcruion of the a.aladc evidence at the time they were written. Health profosaonals arc encouraged to take them ijjy into account when exercising thc

CUPOPCAM soeierr or

ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoctanccs the indhidutl patients, in comdtation with that pitenc md where appropriate and necessity the patients p.urdún or Cirer. k is also the health p

mfesvorxils rrsponsitrfity to verify the rules and reRulitiors ipp/kable to drifts and dcikcs at the time of prescrptksn.© The European Society of Car ESC PAH p HTN pulmonary hypertension 2009 khotailieu y hoc

dotojy 1009. All rtgjnts reserved. for permissions please email >oumals.pcrmisslons(ậk>xfc

CUPOPCAM soeierr or